Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-02

FDA Approved: SILODOSIN — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals Limited's supplemental application for silodosin, allowing a generic version to be marketed. The approval confirms comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

SUPPL AP for SILODOSIN (SILODOSIN)